Gaku Ishikawa
Hamamatsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical benefits, tolerability, and risk factors of adjuvant nivolumab for muscle-invasive bladder cancer.
Journal: Translational andrology and urology
Published: April 11, 2026
Urinary Lipid Profiling for Biomarker Discovery in Clear Cell Renal Cell Carcinoma.
Journal: Anticancer research
Published: March 26, 2026
Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world study.
Journal: Central European journal of urology
Published: December 12, 2025
Current Kidney-Preserving Strategies for Upper Tract Urothelial Carcinoma.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: July 07, 2025
Comparing Perioperative Outcomes Using Single and Multiple Robot Systems During the Learning Period for Robot-Assisted Radical Prostatectomy.
Journal: Asian journal of endoscopic surgery
Published: March 21, 2025
Comparing oncological outcomes and safety between photodynamic diagnosis-assisted and white-light transurethral resection in elderly patients with non-muscle invasive bladder cancer.
Journal: Japanese journal of clinical oncology
Published: December 27, 2024
Use of Preoperative Renal Volumetry to Predict Postdonation Renal Function With Inulin Clearance as Indicator in Japan.
Journal: Transplantation proceedings
Published: December 26, 2024
Comparing Immuno-oncology Combination Therapy With Tyrosine Kinase Inhibitor Monotherapy for Advanced Renal Cell Carcinoma.
Journal: Anticancer research
Published: October 29, 2024
Risk Classification of Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin.
Journal: Cancer diagnosis & prognosis
Published: July 26, 2024
Efficacy and safety of lenvatinib and pembrolizumab as first-line treatment for advanced renal cell carcinoma patients: real-world experience in Japan.
Journal: International journal of clinical oncology
Published: June 04, 2024
Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: September 05, 2022
Renal allograft rejection after treatment with nivolumab in patients with metastatic renal cell carcinoma.
Journal: International cancer conference journal
Published: August 28, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026